AMDA vs. MOTS, SINT, BJDX, OSAP, OSA, RSLS, NMRD, DYNT, BTTX, and BLPH
Should you be buying Amedica stock or one of its competitors? The main competitors of Amedica include Motus GI (MOTS), Sintx Technologies (SINT), Bluejay Diagnostics (BJDX), ProSomnus (OSAP), ProSomnus (OSA), ReShape Lifesciences (RSLS), Nemaura Medical (NMRD), Dynatronics (DYNT), Better Therapeutics (BTTX), and Bellerophon Therapeutics (BLPH). These companies are all part of the "medical" sector.
Amedica (NASDAQ:AMDA) and Motus GI (NASDAQ:MOTS) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, profitability, community ranking, risk, earnings, dividends and valuation.
3.7% of Amedica shares are owned by institutional investors. Comparatively, 20.1% of Motus GI shares are owned by institutional investors. 0.9% of Amedica shares are owned by insiders. Comparatively, 1.6% of Motus GI shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Motus GI has a consensus price target of $28.88, indicating a potential upside of 40,004.17%. Given Motus GI's higher possible upside, analysts clearly believe Motus GI is more favorable than Amedica.
Amedica received 144 more outperform votes than Motus GI when rated by MarketBeat users. However, 65.73% of users gave Motus GI an outperform vote while only 64.90% of users gave Amedica an outperform vote.
Amedica has a beta of -1.24, indicating that its share price is 224% less volatile than the S&P 500. Comparatively, Motus GI has a beta of 1.5, indicating that its share price is 50% more volatile than the S&P 500.
Amedica has a net margin of -139.62% compared to Motus GI's net margin of -4,033.54%. Motus GI's return on equity of 0.00% beat Amedica's return on equity.
In the previous week, Motus GI had 1 more articles in the media than Amedica. MarketBeat recorded 1 mentions for Motus GI and 0 mentions for Amedica. Amedica's average media sentiment score of 0.00 equaled Motus GI'saverage media sentiment score.
Amedica has higher revenue and earnings than Motus GI. Amedica is trading at a lower price-to-earnings ratio than Motus GI, indicating that it is currently the more affordable of the two stocks.
Summary
Motus GI beats Amedica on 10 of the 16 factors compared between the two stocks.
Get Amedica News Delivered to You Automatically
Sign up to receive the latest news and ratings for AMDA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AMDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
